Format

Send to:

Choose Destination
See comment in PubMed Commons below
Aust N Z J Psychiatry. 1993 Mar;27(1):49-55.

A multicentre double blind trial of fluoxetine versus amitriptyline in the treatment of depressive illness.

Author information

  • 1University of Melbourne, Department of Psychiatry, Austin Hospital, Heidelberg, Victoria.

Abstract

The antidepressant efficacy and side effect profile of a fixed dose of 20 mg/day of fluoxetine, a specific serotonin reuptake inhibitor, were compared to those of amitriptyline. Fifty-eight patients with DSM-III-R depression were randomly assigned to receive either fluoxetine or amitriptyline. Fifty-six patients (fluoxetine N = 23, amitriptyline N = 23) completed the 6 week study. Comparable antidepressant efficacy was demonstrated for the two drugs. Patients taking fluoxetine reported less side-effects than those taking amitriptyline.

PMID:
8481170
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk